BPipe Corporation, a Joint Venture Partner of Biopipe Global USA, enters into Agreement with Major Global Food Company to Install 10 m3/day Biopipe Biological Sewage Wastewater Treatment Plant

MANILA, Sep 27, 2022 – (ACN Newswire via SEAPRWire.com) – BPipe Corporation, an equity joint venture partner of Biopipe Global USA, enters into an agreement with a major global food company to install a 10 m3/day Biopipe biological sewage wastewater treatment plant. BPipe Corporation is focused on innovative, scalable and disruptive decentralized wastewater treatment and […]

My prison experience was much tougher than Najib’s, says Anwar

PETALING JAYA – Datuk Seri Anwar Ibrahim says his experience in prison included years in solitary confinement, and was quite different from what Najib Razak is going through. “I was in prison for (years) before being allowed treatment at the Cheras Rehabilitation Hospital (CRH),” the Opposition leader said, referring to calls by Najib’s supporters that […]

ATAL’s Award-Winning AMSFS III Granted Patent in Mainland China

HONG KONG, Sep 15, 2022 – (ACN Newswire via SEAPRWire.com) – Analogue Holdings Limited (stock code: 1977) together with its subsidiaries (referred to as “ATAL Engineering Group”, “ATAL” or the “Group”), a leading electrical and mechanical (“E&M”) engineering services provider in Hong Kong, today announced that the China National Intellectual Property Administration (“CNIPA”) has granted […]

Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA

HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that, on 23 […]

Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease

LAUSANNE, Switzerland, Aug 23, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (‘Oculis’) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, announces that the results of the double blinded, multicenter and placebo controlled Phase 2 clinical trial assessing the effect of topical licaminlimab (OCS-02) on […]

Chinese medical portal censored after doubting herbal ‘Covid remedy’

BEIJING (AFP) – China has censored a popular Chinese medical information site for “violation of relevant laws and regulations”, months after its criticism of a government-backed herbal Covid-19 treatment sent shares in a pharmaceutical giant tumbling. DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the […]

HUTCHMED Initiates a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that it has initiated a bridging study of tazemetostat in China. The first patient received their first dose on July 29, 2022. The bridging study is a multicenter, open-label, Phase II […]

Junshi Biosciences Receives Orphan Medicinal Product Designation from the European Committee for Toripalimab in Treatment of Nasopharyngeal Carcinoma

–6th Orphan Drug Designation granted to toripalimab in the US and EU SHANGHAI, China, July 21, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that toripalimab, a PD-1 inhibitor […]